Home › INDIAGLYCO › Filing
🔔 Get instant alerts when INDIAGLYCO files quarterly results on BSE Start free trial →
India Glycols Limited (INDIAGLYCO)

Press Release

Filed: 17 Nov 2026, 14:40 IST Exchange: NSE Category: Financial Results — Press Release
Press Release - Q2 FY27 - Revenue 358.18 crore; EBITDA 39.34 crore; PAT 11.24 crore (Q2 FY26: Revenue 2410.71 crore; EBITDA 160.25 crore; PAT 53.94 crore) - H1 FY27 revenue 712.82 crore; EBITDA 79.55 crore; PAT 23.59 crore (H1 FY26: Revenue 4913.74 crore; EBITDA 309.51 crore; PAT 106.79 crore) - Results reflect continuing operations post demerger of Spirits & Biofuel and Biopharma units - CEO: Focus on bio-based specialties and performance chemicals with operational efficiency improvements - Strategy to expand business opportunities and create sustainable long-term value
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 INDIAGLYCO — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add INDIAGLYCO to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on India Glycols Limited

Important. The summary above is generated automatically from India Glycols Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.